These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064 [TBL] [Abstract][Full Text] [Related]
7. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Norris SL; Kansagara D; Bougatsos C; Fu R; Ann Intern Med; 2008 Jun; 148(11):855-68. PubMed ID: 18519931 [TBL] [Abstract][Full Text] [Related]
8. Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program. Rosendaal NT; Hendriks ME; Verhagen MD; Bolarinwa OA; Sanya EO; Kolo PM; Adenusi P; Agbede K; van Eck D; Tan SS; Akande TM; Redekop W; Schultsz C; Gomez GB PLoS One; 2016; 11(6):e0157925. PubMed ID: 27348310 [TBL] [Abstract][Full Text] [Related]
9. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
11. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]
12. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029 [TBL] [Abstract][Full Text] [Related]
13. Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention. Dehmer SP; Maciosek MV; LaFrance AB; Flottemesch TJ Ann Fam Med; 2017 Jan; 15(1):23-36. PubMed ID: 28376458 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden. Ekman M; Bienfait-Beuzon C; Jackson J J Hum Hypertens; 2008 Dec; 22(12):845-55. PubMed ID: 18633426 [TBL] [Abstract][Full Text] [Related]